Your browser doesn't support javascript.
loading
Association of plasma biomarkers of fruit and vegetable intake with incident type 2 diabetes: EPIC-InterAct case-cohort study in eight European countries.
Zheng, Ju-Sheng; Sharp, Stephen J; Imamura, Fumiaki; Chowdhury, Rajiv; Gundersen, Thomas E; Steur, Marinka; Sluijs, Ivonne; van der Schouw, Yvonne T; Agudo, Antonio; Aune, Dagfinn; Barricarte, Aurelio; Boeing, Heiner; Chirlaque, María-Dolores; Dorronsoro, Miren; Freisling, Heinz; El-Fatouhi, Douae; Franks, Paul W; Fagherazzi, Guy; Grioni, Sara; Gunter, Marc J; Kyrø, Cecilie; Katzke, Verena; Kühn, Tilman; Khaw, Kay-Tee; Laouali, Nasser; Masala, Giovanna; Nilsson, Peter M; Overvad, Kim; Panico, Salvatore; Papier, Keren; Quirós, J Ramón; Rolandsson, Olov; Redondo-Sánchez, Daniel; Ricceri, Fulvio; Schulze, Matthias B; Spijkerman, Annemieke M W; Tjønneland, Anne; Tong, Tammy Y N; Tumino, Rosario; Weiderpass, Elisabete; Danesh, John; Butterworth, Adam S; Riboli, Elio; Forouhi, Nita G; Wareham, Nicholas J.
  • Zheng JS; MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.
  • Sharp SJ; Key Laboratory of Growth Regulation and Translation Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, China.
  • Imamura F; MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.
  • Chowdhury R; MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.
  • Gundersen TE; MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Steur M; Vitas AS, Oslo, Norway.
  • Sluijs I; MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.
  • van der Schouw YT; Julius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
  • Agudo A; Julius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
  • Aune D; Unit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Group of Research on Nutrition and Cancer, Bellvitge Biomedical Research Institute, L'Hospitalet of Llobregat, Barcelona, Spain.
  • Barricarte A; School of Public Health, Imperial College London, London, UK.
  • Boeing H; Department of Nutrition, Bjørknes University College, Oslo, Norway.
  • Chirlaque MD; Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.
  • Dorronsoro M; Navarra Public Health Institute, Pamplona, Spain.
  • Freisling H; Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • El-Fatouhi D; Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia University, Murcia, Spain.
  • Franks PW; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Fagherazzi G; Public Health Division of Gipuzkoa, San Sebastian, Spain.
  • Grioni S; International Agency for Research on Cancer, Lyon, France.
  • Gunter MJ; Centre of Research in Epidemiology and Population Health, UMR 1018 Inserm, Institut Gustave Roussy, Paris-Sud Paris-Saclay University, Villejuif, France.
  • Kyrø C; Department of Clinical Sciences, Lund University, Malmö, Sweden.
  • Katzke V; Centre of Research in Epidemiology and Population Health, UMR 1018 Inserm, Institut Gustave Roussy, Paris-Sud Paris-Saclay University, Villejuif, France.
  • Kühn T; Luxembourg Institute of Health (LIH), Department of Population Health, Strassen, Luxembourg.
  • Khaw KT; Epidemiology and Prevention Unit, Milan, Italy.
  • Laouali N; International Agency for Research on Cancer, Lyon, France.
  • Masala G; Danish Cancer Society Research Centre, Copenhagen, Denmark.
  • Nilsson PM; Division of Cancer Epidemiology, German Cancer Research Centre, Heidelberg, Germany.
  • Overvad K; Division of Cancer Epidemiology, German Cancer Research Centre, Heidelberg, Germany.
  • Panico S; Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Papier K; Centre of Research in Epidemiology and Population Health, UMR 1018 Inserm, Institut Gustave Roussy, Paris-Sud Paris-Saclay University, Villejuif, France.
  • Quirós JR; Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network, Florence, Italy.
  • Rolandsson O; Department of Clinical Sciences, Lund University, Malmö, Sweden.
  • Redondo-Sánchez D; Department of Public Health, Aarhus University, Aarhus, Denmark.
  • Ricceri F; Department of Cardiology, Aalborg University Hospital, Aarhus, Denmark.
  • Schulze MB; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
  • Spijkerman AMW; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Tjønneland A; Public Health Directorate, Asturias, Spain.
  • Tong TYN; Department of Public Health and Clinical Medicine, Family Medicine, Umeå University, Umeå, Sweden.
  • Tumino R; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Weiderpass E; Andalusian School of Public Health, Granada, Spain.
  • Danesh J; Institute of Biosanitary Research of Granada, Granada, Spain.
  • Butterworth AS; Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
  • Riboli E; Unit of Epidemiology, Regional Health Service ASL TO3, Grugliasco, Turin, Italy.
  • Forouhi NG; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Wareham NJ; German Centre for Diabetes Research, Neuherberg, Germany.
BMJ ; 370: m2194, 2020 07 08.
Article en En | MEDLINE | ID: mdl-32641421
OBJECTIVE: To investigate the association of plasma vitamin C and carotenoids, as indicators of fruit and vegetable intake, with the risk of type 2 diabetes. DESIGN: Prospective case-cohort study. SETTING: Populations from eight European countries. PARTICIPANTS: 9754 participants with incident type 2 diabetes, and a subcohort of 13 662 individuals from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort of 340 234 participants: EPIC-InterAct case-cohort study. MAIN OUTCOME MEASURE: Incident type 2 diabetes. RESULTS: In a multivariable adjusted model, higher plasma vitamin C was associated with a lower risk of developing type 2 diabetes (hazard ratio per standard deviation 0.82, 95% confidence interval 0.76 to 0.89). A similar inverse association was shown for total carotenoids (hazard ratio per standard deviation 0.75, 0.68 to 0.82). A composite biomarker score (split into five equal groups), comprising vitamin C and individual carotenoids, was inversely associated with type 2 diabetes with hazard ratios 0.77, 0.66, 0.59, and 0.50 for groups 2-5 compared with group 1 (the lowest group). Self-reported median fruit and vegetable intake was 274 g/day, 396 g/day, and 508 g/day for participants in categories defined by groups 1, 3, and 5 of the composite biomarker score, respectively. One standard deviation difference in the composite biomarker score, equivalent to a 66 (95% confidence interval 61 to 71) g/day difference in total fruit and vegetable intake, was associated with a hazard ratio of 0.75 (0.67 to 0.83). This would be equivalent to an absolute risk reduction of 0.95 per 1000 person years of follow up if achieved across an entire population with the characteristics of the eight European countries included in this analysis. CONCLUSIONS: These findings indicate an inverse association between plasma vitamin C, carotenoids, and their composite biomarker score, and incident type 2 diabetes in different European countries. These biomarkers are objective indicators of fruit and vegetable consumption, and suggest that diets rich in even modestly higher fruit and vegetable consumption could help to prevent development of type 2 diabetes.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ácido Ascórbico / Verduras / Carotenoides / Diabetes Mellitus Tipo 2 / Frutas Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male País como asunto: Europa Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ácido Ascórbico / Verduras / Carotenoides / Diabetes Mellitus Tipo 2 / Frutas Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male País como asunto: Europa Idioma: En Año: 2020 Tipo del documento: Article